Pravastatin Export Market Intelligence: India's 20 Suppliers Shipping to 17 Countries — TransData Nexus 2026

Q: Who are the top pravastatin exporters from India?

The top pravastatin exporters from India are: 1. INTAS PHARMACEUTICALS LIMITED — $7.6M (24.4% market share); 2. GLENMARK PHARMACEUTICALS LIMITED — $7.5M (24.0% market share); 3. MYLAN LABORATORIES LIMITED — $7.2M (22.9% market share); 4. MEDREICH LIMITED — $4.3M (13.9% market share); 5. STRIDES PHARMA SCIENCE LIMITED — $2.3M (7.5% market share). Together they account for 92.8% of India's total pravastatin export value.

Q: What is the total export value of pravastatin from India?

The total export value of pravastatin from India is $31.2M USD, recorded across 634 shipment transactions from 20 active exporters to 17 destination countries. The average shipment value is $49.2K.

Q: Which countries import pravastatin from India?

India exports pravastatin to 17 countries worldwide. The top importing countries are: UNITED STATES (26.0% share, $8.1M), CANADA (23.6% share, $7.4M), HUNGARY (22.8% share, $7.1M), JAPAN (13.9% share, $4.3M), AUSTRALIA (7.6% share, $2.4M). These five markets account for 93.9% of total export value.

Q: What is the HS code for pravastatin exports from India?

The primary HS code for pravastatin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of pravastatin exports from India?

The average unit price for pravastatin exports from India is $259.20 USD per unit, with prices ranging from $0.01 to $6146.01 depending on formulation, packaging, and order volume. The total market is valued at $31.2M across 634 shipments.

Q: Which ports handle pravastatin exports from India?

The primary ports for pravastatin exports from India are NHAVA SHEVA SEA (INNSA1) (13.4% of shipments), SAHAR AIR (12.3% of shipments), BANGALORE ICD (INWFD6) (7.4% of shipments), HYDERABAD AIR (7.3% of shipments), AHEMDABAD AIR ACC (INAMD4) (6.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of pravastatin?

India is one of the world's leading exporters of pravastatin due to its large base of 20 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports pravastatin to 17 countries, demonstrating 9% global market coverage.

Q: What certifications do Indian pravastatin exporters need?

Indian pravastatin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import pravastatin from India?

There are 77 registered buyers importing pravastatin from India, spread across 17 countries. The repeat buyer rate is 71.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top pravastatin supplier from India?

INTAS PHARMACEUTICALS LIMITED is the leading pravastatin exporter from India with a market share of 24.4% and total export value of $7.6M across 122 shipments. The top 5 suppliers together control 92.8% of total export value.

Suresh Sormare

Pravastatin

India Pharmaceutical Trade Intelligence

$31.2M20 Suppliers17 CountriesHS 30049099

ExportsIndia → UNITED STATES26.0%India → CANADA23.6%

ImportsHUNGARY → India$17.5K CANADA → India$5.6K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: MYLAN HUNGARY

Pravastatin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Pravastatin to the World

Between 2022 and 2026, India exported $31.2M worth of pravastatin across 634 verified shipments to 17 countries — covering 9% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (26.0%). INTAS PHARMACEUTICALS LIMITED leads with a 24.4% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Pravastatin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Pravastatin export data snapshot — $31.2M · 20 exporters · 17 countriesTransData Nexus · Indian Customs Data

Top Pravastatin Exporters from India

20 active exporters · Ranked by export value

View all 20 →

Top Pravastatin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	INTAS PHARMACEUTICALS LIMITED	$7.6M	122	9	24.4%
2	GLENMARK PHARMACEUTICALS LIMITED

Top Countries Importing Pravastatin from India

17 destination markets · Ranked by import value

All 17 countries →

Top Countries Importing Pravastatin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$8.1M	26.0%
2	CANADA	$7.4M	23.6%
3	HUNGARY	$7.1M	22.8%
4	JAPAN	$4.3M	13.9%
5	AUSTRALIA	$2.4M	7.6%
6	SPAIN	$586.5K	1.9%
7	FRANCE	$427.6K	1.4%
8	UNITED KINGDOM	$204.7K	0.7%
9	SERBIA	$203.0K	0.7%
10	GERMANY	$199.0K	0.6%

UNITED STATES is India's largest pravastatin export destination, absorbing 26.0% of total exports worth $8.1M. The top 5 importing countries — UNITED STATES, CANADA, HUNGARY, JAPAN, AUSTRALIA — together account for 93.9% of India's total pravastatin export value. The remaining 12 destination countries collectively receive the other 6.1%, indicating a focused distribution strategy targeting key markets.

Who Supplies Pravastatin to India?

5 origin countries · Total import value: $28.1K

India imports pravastatin from 5 countries with a combined import value of $28.1K. The largest supplier is HUNGARY ($17.5K, 7 shipments), followed by CANADA and ISRAEL. All values are from Indian Customs (DGFT) import records.

Countries Supplying Pravastatin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	HUNGARY	$17.5K	7	62.3%
2	CANADA	$5.6K	51	19.8%
3	ISRAEL	$4.4K	10	15.8%
4	UNITED STATES	$476	5	1.7%
5	CHINA	$113	2	0.4%

HUNGARY is the largest supplier of pravastatin to India, accounting for 62.3% of total import value. The top 5 origin countries — HUNGARY, CANADA, ISRAEL, UNITED STATES, CHINA — together supply 100.0% of India's pravastatin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Pravastatin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, pravastatin is approved for the treatment of hypercholesterolemia and for the prevention of cardiovascular events. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for pravastatin, indicating a competitive generic market. Notably, the top five Indian exporters collectively contributed to 73.2% of pravastatin exports, underscoring India's significant role in supplying the U.S. market. As of March 2026, there are no active FDA import alerts or enforcement actions specifically targeting pravastatin, suggesting compliance with U.S. regulatory standards.

2EU & UK Regulatory Framework

In the European Union, pravastatin is authorized for use in managing hypercholesterolemia and preventing cardiovascular events. The European Medicines Agency (EMA) conducted a referral procedure for Pravachol (pravastatin) to harmonize product information across member states, concluding with a favorable benefit-risk assessment in March 2004. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA guidelines, ensuring consistent regulatory standards post-Brexit. Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers exporting to these markets.

3WHO Essential Medicines & Global Standards

Pravastatin is included in the World Health Organization's Model List of Essential Medicines, highlighting its importance in global health. It meets international pharmacopoeial standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, pravastatin is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) has not set a specific ceiling price for pravastatin, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for pravastatin have expired, leading to a robust generic market with multiple manufacturers producing the drug. This has resulted in increased competition and more affordable pricing globally.

6Recent Industry Developments

In June 2025, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) completed a periodic safety update report (PSUR) for pravastatin, concluding that the benefit-risk balance remains favorable. (ema.europa.eu) In September 2025, the WHO updated its Essential Medicines List, reaffirming the inclusion of pravastatin for managing dyslipidemia. In December 2025, the NPPA conducted a review of lipid-lowering agents, including pravastatin, to assess market dynamics and pricing strategies. In February 2026, the FDA approved a new generic formulation of pravastatin, further enhancing market competition. In March 2026, the CDSCO issued updated guidelines for the export of pharmaceutical products, emphasizing compliance with international quality standards.

These developments reflect the dynamic regulatory landscape surrounding pravastatin, underscoring the importance of continuous monitoring and compliance for stakeholders involved in its production and distribution.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Pravastatin

Retail & reference prices across 9 markets vs. India FOB export price of $259.20/unit

Global Price Benchmark for Pravastatin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.06	USD	According to data from a U.S. national survey conducted on February 18, 2026, the average pharmacy acquisition cost for Pravastatin Sodium 10 mg tablets is $0.06181 per unit.
United Kingdom	$1.31	GBP	A study published in July 2021 indicates that the price of Atorvastatin 10 mg in the UK was £0.92 per tablet. While this data pertains to Atorvastatin, it provides a contextual benchmark for statin pricing in the UK.
Germany	$1.42	EUR	The same July 2021 study reports that the price of Atorvastatin 10 mg in Germany was €1.29 per tablet. This serves as a reference point for statin pricing in the German market.

Supply Chain Risk Assessment — Pravastatin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned as the "pharmacy of the world," heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) production. Approximately 60–70% of these critical inputs are imported from China, exposing the supply chain to potential disruptions.

This dependency became evident during the COVID-19 pandemic in early 2020, when China's lockdowns led to significant supply chain interruptions. The situation underscored the risks associated with over-reliance on a single country for essential raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters of Pravastatin account for 92.8% of total exports, with INTAS PHARMACEUTICALS LIMITED leading at a 24.4% share. This high concentration poses a risk, as any disruption affecting these key suppliers could significantly impact global supply.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme in 2020, aiming to boost domestic production of APIs and reduce import dependency. However, as of March 2026, the scheme's impact on diversifying Pravastatin suppliers remains limited, with the market still dominated by a few key players.

Access Complete Pravastatin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 634 transactions across 17 markets.

Request Demo View Pricing

Frequently Asked Questions — Pravastatin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top pravastatin exporters from India?

The leading pravastatin exporters from India are INTAS PHARMACEUTICALS LIMITED, GLENMARK PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, and 11 others. INTAS PHARMACEUTICALS LIMITED leads with 24.4% market share ($7.6M). The top 5 suppliers together control 92.8% of total export value.

What is the total export value of pravastatin from India?

The total export value of pravastatin from India is $31.2M, recorded across 634 shipments from 20 active exporters to 17 countries. The average shipment value is $49.2K.

Which countries import pravastatin from India?

India exports pravastatin to 17 countries. The top importing countries are UNITED STATES (26.0%), CANADA (23.6%), HUNGARY (22.8%), JAPAN (13.9%), AUSTRALIA (7.6%), which together account for 93.9% of total export value.

What is the HS code for pravastatin exports from India?

The primary HS code for pravastatin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Pravastatin

Pravastatin

Top Pravastatin Exporters from India

Top Countries Importing Pravastatin from India

Who Supplies Pravastatin to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Regulatory Landscape — Pravastatin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Pravastatin

Supply Chain Risk Assessment — Pravastatin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Pravastatin Trade Intelligence

Frequently Asked Questions — Pravastatin Exports from India

Who are the top pravastatin exporters from India?

What is the total export value of pravastatin from India?

Which countries import pravastatin from India?

What is the HS code for pravastatin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of pravastatin exports from India?

Which ports handle pravastatin exports from India?

Why is India a leading exporter of pravastatin?

What certifications do Indian pravastatin exporters need?

How many buyers import pravastatin from India?

What is the market share of the top pravastatin exporter from India?

Analysis Methodology